UTI Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index
NAV: ₹376.9-1.20%
17 Jul 2026
Rolling Returns Analysis
Rolling annualized returns of UTI Healthcare Fund Direct-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 07 Jan, 2014 - 17 Jul, 2026 | 22 Jan, 2016 - 17 Jul, 2026 | 01 Feb, 2018 - 17 Jul, 2026 | 17 Feb, 2020 - 17 Jul, 2026 |
| Average returns | 18.87% | 14.97% | 14.15% | 14.44% |
| Standard deviation | 24.72% | 10.57% | 7.55% | 4.66% |
| Best returns | 86.11% 1 year ending on 30 Mar, 2021 | 30.14% 3 years ending on 04 Jul, 2025 | 31.82% 5 years ending on 12 Sep, 2024 | 24.17% 7 years ending on 16 Jul, 2026 |
| Worst returns | -17.53% 1 year ending on 19 Sep, 2019 | -6.87% 3 years ending on 07 Oct, 2019 | -2.96% 5 years ending on 23 Mar, 2020 | 5.39% 7 years ending on 12 May, 2022 |
| Period with positive return | 68.35% | 82.96% | 98.90% | 100.00% |
| Period with return > 5% | 57.90% | 74.52% | 88.38% | 100.00% |
| Period with return > 10% | 52.55% | 71.77% | 73.82% | 78.38% |
| Period with return > 15% | 47.48% | 63.32% | 37.08% | 46.02% |
| Beat % Category | 30.87% | 18.36% | 5.76% | 2.40% |
| Beat % Benchmark | 77.09% | 93.65% | 99.81% | 100.00% |
Trailing Returns
Point-to-point returns of UTI Healthcare Fund Direct-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
17.2%
14.9%
13.4%
YTD
6.1%
5.9%
6.4%
1 M
19.8%
16.9%
16.0%
6 M
12.7%
11.9%
13.9%
1 Y
26.4%
23.2%
45.5%
3 Y
15.4%
14.6%
12.7%
5 Y
14.8%
15.3%
9.1%
10 Y
Fund
Equity: Sectoral-Pharma
BSE Healthcare Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 17.19% | 6.08% | 19.83% | 12.69% | 26.40% | 15.37% | 14.78% | 16.48% |
| Equity: Sectoral-Pharma | 14.89% | 5.90% | 16.85% | 11.86% | 23.21% | 14.58% | 15.26% | - |
| BSE Healthcare Total Return Index | 13.41% | 6.37% | 16.00% | 13.89% | 45.45% | 12.73% | 9.06% | - |
| Rank in category | 5 | 11 | 4 | 9 | 1 | 3 | 3 | - |
| Funds in category | 21 | 22 | 21 | 20 | 9 | 7 | 3 | - |
Period Returns
Calendar-year, quarterly and monthly return history of UTI Healthcare Fund Direct-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of UTI Healthcare Fund Direct-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of UTI Healthcare Fund Direct-Growth?
UTI Healthcare Fund Direct-Growth has delivered a 1-year return of 12.69% as of 16 Jul 2026. During the same period, its benchmark BSE Healthcare Total Return Index returned 13.89%. The fund has underperformed its benchmark over this period.
What are the 3-year returns of UTI Healthcare Fund Direct-Growth?
UTI Healthcare Fund Direct-Growth has delivered a 3-year CAGR of 26.40% as of 16 Jul 2026. Its benchmark BSE Healthcare Total Return Index returned 45.45% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year mutual fund performance as it smooths out year-to-year volatility.
What are the 5-year returns of UTI Healthcare Fund Direct-Growth?
UTI Healthcare Fund Direct-Growth has delivered a 5-year CAGR of 15.37% as of 16 Jul 2026. Its benchmark BSE Healthcare Total Return Index returned 12.73% CAGR over the same period. A 5-year track record is considered a more reliable indicator of fund quality than shorter-term performance, as it captures at least one full market cycle.
What are the returns of UTI Healthcare Fund Direct-Growth since inception?
Since its launch on 31 Dec 2012, UTI Healthcare Fund Direct-Growth has delivered a CAGR of 16.48%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has UTI Healthcare Fund Direct-Growth performed vs its category over the long term?
Over the long term, UTI Healthcare Fund Direct-Growth has ranked 1 out of 9 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and 3 out of 7 funds on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of UTI Healthcare Fund Direct-Growth?
The Sharpe ratio of UTI Healthcare Fund Direct-Growth is 1.19 (as of 16 Jul 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of UTI Healthcare Fund Direct-Growth?
The 3Y alpha of UTI Healthcare Fund Direct-Growth is 2.17% (as of 16 Jul 2026). Alpha measures the excess return generated by the fund over and above its benchmark BSE Healthcare Total Return Index, after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of UTI Healthcare Fund Direct-Growth?
The beta of UTI Healthcare Fund Direct-Growth is 0.96 (as of 16 Jul 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark BSE Healthcare Total Return Index. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. UTI Healthcare Fund Direct-Growth's beta of 0.96 indicates it is more defensive than its benchmark.
What are the rolling returns of UTI Healthcare Fund Direct-Growth?
The average 1-year and 3-year rolling returns of UTI Healthcare Fund Direct-Growth is 18.87% and 14.97% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.